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CLINICAL STUDY
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Abstract
Objective. To compare the postoperative complication rates after hysterectomy between HIV-infected patients and HIV-
uninfected patients.
Study design. We conducted a retrospective study of 24 human immunodeﬁciency virus-infected patients who underwent
hysterectomy between January 1, 2000 and April 2, 2003 at Grady Memorial Hospital. Postoperative complications rates
among HIV-infected women were compared to those rates among HIV-uninfected women. Data were analyzed t-tests for
continuous variables and chi-squared tests for categorical variables.
Results. The HIV-infected women were more likely to report smoking and recreational drug use. In addition, a higher
proportion of the HIV-infected women were co-infected with hepatitis, with more than one-quarter of HIV-infected women
being hepatitis B or C seropositive. Although the study was limited due to small sample size, no signiﬁcant differences in
complication rates were found among HIV-infected women compared with uninfected women.
Conclusion. As HIV-infected women are living longer, healthier lives we anticipate that increased numbers of HIV-infected
women will be undergoing hysterectomy for benign gynecologic conditions. It will be important, therefore, to carefully
document any potential differences in operative risks.
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Introduction
Women are increasingly affected by HIV; more than
one-ﬁfth of all persons living with AIDS in the
United States are women [1]. Since hysterectomy is
the one of the most common non-obstetrical major
surgical procedures that women undergo, one would
expect that a sizeable number of HIV-infected
women would undergo hysterectomy. In addition,
some conditions that may lead to hysterectomy, such
as cervical dysplasia, are more common in HIV-
infected women. Therefore, we retrospectively re-
viewed the clinical experience of HIV-infected
women undergoing hysterectomy compared to
HIV-uninfected women undergoing hysterectomy.
Methods
All women who underwent hysterectomy from
January 1, 2000 to April 2, 2003 were selected from
a surgical database which contains all surgery
performed at Grady Memorial Hospital. Among
the 745 hysterectomy cases, 27 (4%) women were
known to be HIV-infected at the time of their
surgery. Three women were excluded who under-
went surgery for a malignancy.
For the 24 eligible HIV-infected women, two
control groups were established. Both control groups
were matched by age (+8 years), primary indication
for surgery (infectious vs. non-infectious), major
medical complication (such as poorly controlled
diabetes, hypertension), past surgical history (major
abdominal surgery, not including cesarean section),
and type of procedure performed. In addition to the
above factors, the ﬁrst control group was matched by
uterine weight and the second was matched by
operating time.
The primary outcome of interest was the complica-
tion rate associated with hysterectomy. The
complication rate was deﬁned as having one or more
of the following complications: postoperative febrile
morbidity, wound infection, postoperative urinary
tract infection, re-admission to the hospital, re-
operation, intra-operative or postoperative blood
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deﬁned as a temperature of greater than 38.08Co n
two separate occasions eight or more hours apart or
one temperature of 38.08C with the use of antibiotics.
The HIV-infected group was compared to each of
the control groups in separate comparisons. Differ-
ences between means were evaluated using t-tests;
differences between categorical variables were as-
sessed using chi-squared tests.
Results
The mean age of women undergoing hysterectomy
was approximately 40 years and the mean operating
time was approximately 2.5 h. Most surgery was
done for non-infectious indications, with the most
common indication for surgery being uterine leio-
myomas. More HIV-infected women underwent
hysterectomy for cervical dysplasia compared with
uninfected women. In terms of procedure, 16
women in each group underwent a total vaginal
hysterectomy including 2 in each group who under-
went laparosopic-assisted vaginal hysterectomy. The
remaining women underwent abdominal hysterect-
omy including one woman undergoing a supra-
cervical hysterectomy (Table I).
Among the 24 HIV-infected women, 42% had a
CD4 count of above 500 cells/ml, and 21% had a
plasma viral load of 5400 copies/mL. 46% of the
women had documentation that they were currently
taking antiretroviral therapy at the time of the surgery
(Table II). When compared with controls, signiﬁ-
cantly more HIV-infected women reported smoking
and recreational drug use. In addition, a higher
proportion of HIV-infected women were known to
be hepatitis B and C seropositive, with more than a
quarter of HIV-infected women co-infected with
either hepatitis B or C, or both.
Overall, the complication rates among all groups
were similar. Among the HIV-infected women, there
Table I. Characteristics of the 72 women in the study population.
HIV-infected
HIV-uninfected controls
matched by uterine weight
HIV-uninfected controls
matched by operating time
N=24 N=24 N=24
Age, years (mean)* 40.5 41.5 40.2
Uterine weight, grams (mean)* 253 231 341
Operating time, minutes (mean)* 147 133 146
Primary indication*
Uterine leiomyomata 7 (29%) 12 (50%) 11 (46%)
Cervical dysplasia 7 (29%) 1 (4%) 0 (0%)
Pelvic pain 3 (13%) 5 (21%) 8 (33%)
Menometorrhagia 1 (4%) 2 (8.3%)
Prolapse 1 (4%) 1 (4%) 2 (8%)
Pelvic mass 3 (13%) 1 (4%) 0 (0%)
Tubo-ovarian abscess 2 (8%) 2 (8%) 2 (8%)
Surgical approach*
Vaginal 16 (67%) 16 (67%) 16 (67%)
Abdominal 8 (33%) 8 (33%) 8 (33%)
Current tobacco use 15 (63%) 7 (29%)** 8 (33%)**
History of drug use 10 (42%) 3 (13%)** 0 (0%)**
Hepatitis B seropositivity 5 (21%) 1 (4%)** 1 (4%)**
Hepatitis C seropositivity 6 (25%) 0 (0%)** 0 (0%)**
Operative/post-operative complication 9 (38%) 4 (17%) 8 (33%)
Estimated blood loss, cc (mean) 460 434 537
Total length of hospitalization, days (mean) 6 3.8 4
Length of post-operative hospitalization, days (mean) 3.1 2.3 2.5
* Variables which were used in matching; ** P-value 50.05 for comparison of control group vs. HIV-infected group.
Table II. Characteristics of 24 HIV-infected women at time of
surgery.
Characteristic N (%)
CD4 count (cells/ml)
5200 3 (12%)
200–350 6 (25%)
350–500 5 (21%)
4500 10 (42%)
Plasma viral load (copies/mL)
4400 5 (21%)
401–2,500 5 (21%)
2,501–5,000 5 (21%)
5,001–10,000 0 (0%)
410,000 4 (17%)
Unknown 5 (21%)
Current antiretroviral therapy
Yes 11 (46%)
No documentation in chart 13 (54%)
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including febrile morbidity (6), urinary tract infec-
tion (1), readmission (3), re-operation (1), and
intraoperative blood transfusion (1). Among the 9
HIV-infected women who experienced a postopera-
tive complication, one woman had a CD4 count of
less than 200 cells/ml and one woman had a viral load
of greater than 10,000 copies/mL. Among the HIV-
uninfected women matched by uterine weight, there
were 4 complications among 4 women including
febrile morbidity (2), re-admission (1), and paralytic
ileus (1). Among the HIV-uninfected women
matched by operating time, there were 8 complica-
tions among 8 women including febrile morbidity
(1), wound infection (1), re-admission (1), re-
operation (1), blood transfusion (3), and paralytic
ileus (1). The estimated blood loss was similar in the
different groups (approximately 500 cc) as were the
post-operative hospitalization lengths (2–3 days).
Discussion
The issue about whether or not peri-operative
morbidity is greater among HIV-infected women
when compared to uninfected women has primarily
focused on cesarean section. Much less has been
reported about the experience of HIV-infected
women undergoing gynecologic surgery and results
to date have been conﬂicting.
In the present study, which included 24 HIV-
infected women undergoing hysterectomy, we were
not able to demonstrate a statistically signiﬁcant
increase in peri-operative morbidity among HIV-
infected women when compared to two different
control groups. However, we were also not able to
deﬁnitively demonstrate that there were no differ-
ences given our small sample size. Assuming a three-
fold increase in the overall complication rate, we had
only 40% power to detect a difference.
However, most prior reports have also had
extremely limited sample size and were not able to
look at hysterectomy separately from other gyneco-
logic procedures. For example, one report by
Grubert et al. included 235 surgical procedures,
with only 72 being major and including cesarean
section, tubal ligation, and oophorectomy in addition
to hysterectomy. They reported a higher complica-
tion rate in the HIV-infected group [2]. Another
report by Sewell et al. reviewed 53 surgical proce-
dures with only 9 hysterectomies; the majority of
procedures were minor. They showed no difference
in outcome between the HIV-infected women and
the uninfected women [3].
An additional limitation of this study is that it was
retrospective, and therefore was limited by the
information contained in the medical record. De-
tailed information about the level of training of the
primary surgeon was not available since the attending
physician was uniformly recorded as the physician of
record. In addition, clinical decisions such as use of
antibiotics were made based upon clinical judgment
rather than prospectively determined by a clinical
algorithm. These decisions were likely inﬂuenced by
the HIV status of the patient, since this information
was available to the clinician. Additionally, since
there is not universal HIV screening prior to surgery,
some women included in the uninfected control
group may have been HIV-infected. If some of the
women in the control group were HIV-infected, this
could have biased our results toward the null, with
the control group appearing to having an abnormally
elevated complication rate and obscuring any differ-
ences between the two groups.
As HIV-infected women are living longer, heal-
thier lives in large part due to advances in
antiretroviral therapy, we can anticipate that in-
creased numbers of HIV-infected women will be
seeking gynecologic surgery for a variety of benign
conditions. It will be important to document whether
the risks associated with gynecologic procedures
such as hysterectomy are any different among HIV-
infected women as compared to uninfected women.
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